Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Angiotensin Receptor Blocker for Stroke Prevention in Atrial Fibrillation: beyond Blood Pressure Lowering?

  • Choi, Eue-Keun (Division of Cardiology, Department of Internal Medicine, Seoul National University Hospital)
  • Received : 2016.04.11
  • Accepted : 2016.04.29
  • Published : 2016.05.30
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369-429. https://doi.org/10.1093/eurheartj/ehq278
  2. Schneider MP, Hua TA, Bohm M, Wachtell K, Kjeldsen SE, Schmieder RE. Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis. J Am Coll Cardiol 2010;55:2299-307. https://doi.org/10.1016/j.jacc.2010.01.043
  3. Touyz RM, Schiffrin EL. Effects of angiotensin II and endothelin-1 on platelet aggregation and cytosolic pH and free Ca2+ concentrations in essential hypertension. Hypertension 1993;22:853-62. https://doi.org/10.1161/01.HYP.22.6.853
  4. Remkova A, Remko M. The role of renin-angiotensin system in prothrombotic state in essential hypertension. Physiol Res 2010;59:13-23.
  5. Murad JP, Espinosa EV, Ting HJ, Khasawneh FT. Characterization of the in vivo antiplatelet activity of the antihypertensive agent losartan. J Cardiovasc Pharmacol Ther 2012;17:308-14. https://doi.org/10.1177/1074248411425491
  6. Sakamoto T, Kudoh T, Sakamoto K, Matsui K, Ogawa H. Antithrombotic effects of losartan in patients with hypertension complicated by atrial fibrillation: 4A (Angiotensin II Antagonist of platelet Aggregation in patients with Atrial fibrillation), a pilot study. Hypertens Res 2014;37:513-8. https://doi.org/10.1038/hr.2014.22
  7. Choi JI, Jung JS, Kim MK, et al. Effects of angiotensin-II receptor blocker on inhibition of thrombogenicity in a canine atrial fibrillation model. Korean Circ J 2016;46:335-42. https://doi.org/10.4070/kcj.2016.46.3.335